February 02, 2016
Researchers at Drexel Neurosciences Institute have begun a landmark study to determine if a new drug can postpone or even prevent Alzheimer's disease. The study examines healthy people whose brain scans show the build up of a protein associated with the disease — but who do not yet have any memory loss or other symptoms. The study will determine if an investigational treatment can clear the built-up plaque of the protein, called amyloid, before the disease progresses and brain cells are impaired.
Read More